Kalkine has a fully transformed New Avatar.
Stocks’ Details
Cadence Capital Limited
Outperformed All Ordinary Accum. Index: Cadence Capital Limited (ASX: CDM) makes investments in securities listed both in Australia and internationally. The market capitalisation of the company stood at $262.48 million as on 16th December 2020. As on 30th November 2020, the company’s Pre-Tax Net Tangible Assets (NTA) stood at $0.975, and Post Tax NTA was $1.109. During FY20, the company experienced a fall of 4.9% in the fund’s gross performance. However, the company’s portfolio has outperformed All Ords. Accum. Index by 2.3%. Loss for the year amounted to $10.9 million. The company also declared a fully franked final dividend of 2.0 cents per share, which brought the full-year 2020 dividend to 4.0 cents per share.
Financial Summary (Source: Company Reports)
Outlook: Looking forward, the company is expecting to be benefited from the recovery in global financial markets from the lows in March 2020. In addition, the company expects significant market share opportunities in each sector on the back of recent recovery.
Stock Recommendation: The company has bought back 7,818,236 ordinary shares at the consideration of $5,570,030.17, with respect to on-market share buy-back of up to 10% of CDM shares. In the past six and nine months, the stock of CDM has surged 40.80% and 114.63%, respectively. As a result, the stock is inclined towards its 52-week high level of $0.885. In addition, we have also considered 14-day RSI, and it was observed that the stock is currently in the overbought zone and may witness some correction going forward. On a technical analysis front, the stock has a support level of ~$0.767 and a resistance level of ~$0.920. Considering the steep returns in the past few months, current trading levels, and RSI level, we suggest investors to book profit and give a “Sell” rating on the stock at the current market price of $0.880 per share, up by 0.571% on 16th December 2020.
SRG Global Limited
Strong Demand for Services: SRG Global Limited (ASX: SRG) provides engineering-led specialist asset services, mining services and construction services across the entire asset lifecycle. The market capitalisation of the company stood at $182.77 million as on 16th December 2020. Recently, the company stated that the significant level of new contract wins and the record work in hand of $1 billion as on 30th November 2020, showcases the robust demand for its engineering-led, end-to-end solutions in the asset services, mining services and construction sectors. For FY20, the company recorded revenue and EBITDA amounting to ~ $545 million and $20.5 million, respectively. In addition, the company’s revenue in 2H FY20 decreased to $8.4 million.
Key Financials (Source: Company Reports)
Guidance: The company recently updated its guidance and expects EBITDA in the range of $19m - $20m for 1H FY21 and EBITDA of between $42m - $45m for FY21 as compared to previous guidance of $38m - $42m.
Valuation Methodology: Price to Earnings Multiple Based Relative Valuation (Illustrative)
Price to Earnings Multiple Based Relative Valuation (Source: Refinitiv, Thomson Reuters)
Note: All forecasted figures and peers have been taken from Thomson Reuters, NTM-Next Twelve Months
Stock Recommendation: Looking forward, the company expects to secure a near-term contract with repeat and targeted clients. The stock of SRG has moved up by 95.34% in the last six months. As a result, the stock is trading towards its 52-week high level of $0.435. We have valued the stock using the price to earnings multiple based illustrative relative valuation method and arrived at a target price with correction of low double-digit (in percentage terms). For the purpose, we have taken peers such as GR Engineering Services Ltd (ASX: GNG), Boral Ltd (ASX: BLD) and Fletcher Building Ltd (ASX: FBU). In addition, we have also considered 14-day RSI, and it was observed that the stock is currently in the overbought zone and may witness some correction going forward. On a technical analysis front, the stock has a support level of ~$0.274 and a resistance level of ~$0.561. Considering the returns in the past few months, current trading levels, RSI levels, and valuation, we suggest investors to book profit and give a “Sell” rating on the stock at the current market price of $0.420 per share, up by 2.439% on 16 December 2020.
Peninsula Energy Limited
Signing of Binding Agreement with UG USA: Peninsula Energy Limited (ASX: PEN) is engaged in the development and mining of uranium. The market capitalisation of the company stood at $98.26 Mn as on 16th December 2020. For the year ended 30th June 2020, the company recorded revenue amounting to ~US$6.0 million as compared to ~US$6.5 million in FY19. Loss for the year amounted to ~US$7.0 million against ~US$ 43 million in FY19. In the month of July 2020, the company reached a binding purchase agreement with UG USA, which is a subsidiary company of ORANO. As per the terms of the agreement, the company will purchase 400,000 lbs U3O8 for delivery in CY21. This agreement is likely to support its forecast net cash margin of US$6 million to US$8 million in uranium sales for the upcoming year.
Financial Summary (Source: Company)
Outlook: PEN holds a portfolio of uranium concentrate sale agreements for up to 5.5 million pounds U3O8 as on 30th September 2020. The company added that the delivery obligations under the contracts are expected to continue through to 2030 with a weighted average forthcoming sales price at the high end of the guided ambit of US$51-$53 per pound.
Stock Recommendation: As on 30th June 2020, the cash and cash equivalents of the company stood at ~US$11.93 million as compared to ~US$5.2 million as on 30th June 2019. In the last one and three months, the stock has moved up by 58.45% and 67.91%, respectively. The 52-week low-high range for the stock stands at $0.056 - $0.188, respectively. We have considered 14-day RSI, and it was observed that the stock is currently in the overbought zone and may witness some correction going forward. On a technical analysis front, the stock has a support level of ~$0.0947 and a resistance level of ~$0.13. Considering the decent returns in the past few months, current trading levels, RSI levels, and key risks associated with the business, we suggest investors to book profit and give a “Sell” rating on the stock at the current market price of $0.115 per share, up by 4.545% on 16th December 2020.
Comparative Price Chart (Source: Refinitiv, Thomson Reuters)
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as personalised advice.